Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo

 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
 

 
HOME >> PRODUCTS >> Taj Products >> ALTRAM
Taj  ALL Products View Products According to Category


Composition
ALTRAM ®
capsule: Each capsule contains Tramadol Hydrochloride BP 50 mg.
ALTRAM ®100 Injection: Each 2 ml injection contains Tramadol Hydrochloride BP 100 mg.
ALTRAM ® 50 Injection: Each 1 ml injection contains Tramadol Hydrochloride BP 50 mg.
ALTRAM
® 100 suppository: Each suppository contains Tramadol Hydrochloride BP 100 mg.
Pharmacology
ALTRAM ®
(Tramadol) is a centrally acting synthetic analgesic compound. It inhibits the re
uptake of neurotransmitters- serotonin and noradrenaline. Thus it modifies the
transmission of pain impulses by activating both descending serotonergic pathways and
noradrenergic pathways involved in analgesia. The analgesic effects of Tramadol are
mediated via stimulation of mu-opioid receptors and indirect modulation of central
monoaminergic inhibitory pathways.
Indication
ALTRAM ®
(Tramadol) is used for the treatment of moderate to severe painful conditions.
These include:
Ø Post-operative pain
Ø Colic and spastic pain
Ø Cancer pain
Ø Joint pain
Ø Neck and back pain
Ø Pain associated with osteoporosis
Ø Chest pain (including pain associated with myocardial infarction and angina) etc.
Dosage and Administration

ALTRAM ®
capsule: Usual doses are 50 to 100 mg every four to six hours. For acute pain an initial dose of
100 mg is required. For chronic painful conditions as initial dose of 50 mg is
recommended. Subsequent doses should be 50 to 100 mg administered 4-6 hourly. The
dose level and frequency of dosing will depend on the severity of the pain. The total
daily dosage by mouth should not exceed 400 mg.
ALTRAM ® injection:
A dose of 50-100 mg may be given every 4 to 6 hours by intramuscular or by
intravenous infusion. For the treatment of post-operative pain, the initial dose is 100 mg
followed by 50 mg every 10 to 20 minutes if necessary to a maximum of 250 mg in the
first hour. Thereafter, doses are 50 to 100 mg every 4 to 6 hours up to a total daily dose
of 600 mg.
ALTRAM ®
suppository:
ALTRAM ® suppository should be administered rectally. For adults usual dose is one
suppository 6 hourly. In general, 400 mg Tramadol Hydrochloride (= 4 ALTRAM ® suppository) per day sufficient. However, for the treatment of Cancer pain and severe
pain after operations much higher daily doses can be used.
Side-Effects
Commonly occurring side-effects are dizziness/vertigo, nausea, constipation, headache,
somnolence, vomiting, pruritus, CNS stimulation, asthenia, sweating, dyspepsia, dry
mouth, diarrhoea.
Less commonly occurring side-effects include malaise, allergic reaction, weight loss,
vasodilatation, palpitations, abdominal pain, anorexia, flatulence, GI bleeding, hepatitis,
stomatitis etc.
Contraindication
Tramadol is contraindicated in persons having hypersensitivity to this drug. It is also
contraindicated in acute intoxication with alcohol, hypnotics, centrally acting analgesics,
opioids or psychotropic drugs.
Drug Interaction
In general, physician need not be concerned about drugs interacting with Tramadol. The
monoamine oxidase (MAO) inhibitors represent the only drug class not recommended
for combination with Tramadol.
Concomitant administration of carbamazepine with Tramadol causes a significant
increase in Tramadol metabolism and it requires to increase the dose of Tramadol.
Precaution
Respiratory depression: When large doses of tramadol are administered with
anaesthetic with anaesthetic medications or alcohol, respiratory depression may result.
Therefore, tramadol should be administered cautiously in patients at risk for respiratory depression. Opioid dependence: Tramadol is not recommended for patients who are dependent on opioids. Concomitant CNS depressants: Tramadol should be used with caution and in reduced dosages when administering to patients receiving CNS depressants such as alcohol, opioids, anesthetic agents, phenothiazines, tranquilizers or sedative hypnotics.
Concomitant MAO inhibitors : Tramadol should be used with great caution in patients taking MAO inhibitors, since tramadol inhibits the uptake of norepinephrine and
serotonin. Tramadol should be used with caution in patients with increased intracranial pressure or head injury and patients with acute abdominal conditions.
Use in Pregnancy and Lactation
Safe use of tramadol in pregnancy has not been established. Tramadol has been shown to cross the placenta. There are no adequate and well controlled studies in pregnant women. Therefore, tramadol should be used during pregnancy only if the potential benefit justifies the risk to the foetus.
Use in Children
In children from the age of one year ALTRAM (Tramadol) can be given in a dose of 1-2 mg/kg body weight. However, on account of the dosage strength of ALTRAM suppository (100 mg Tramadol Hydrochloride) should not be administered in children and adolescents below the age of
14 years.


How Supplied
ALTRAM®capsule: Box containing 3x10’s capsules in blister pack.
ALTRAM® 100 injection: Each box containing 1x5’s ampoules in blister pack.
ALTRAM ®50 injection: Each box containing 1x5’s ampoules in blister pack.
ALTRAM ® 100 suppository : Box containing 1x5’s suppositories in blister pack.
 

® Registered Trade Mark TAJ PHARMA
 








Note :
This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.

Information for Health Care Professionals

*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited).

 

 

 


 

 




centrally acting analgesic









 
 
 
 

 

 


 

 

 

 


              
 Print page   Send by mail

 

 

 

 

 

   
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 
 www.tajpharma.com

   

 

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement